Information events for NHS commissioners and providers showcase how to procure cost-saving innovations

Posted on 24 March 2017 (Permalink)

The NHS Innovation Accelerator (NIA) is to host a series of information events in partnership with local Academic Health Science Networks (AHSNs) - including one in Birmingham - to demonstrate how NHS commissioners and providers can be reimbursed for the procurement of cost-saving, outcomes-based innovations.

The ‘Improving outcomes, cutting costs’ events will specifically showcase the five NIA innovations available to procure via central funding and the new Innovation and Technology Tariff (ITT) from 1 April 2017. NHS England will also be introducing the ITT and providing insight as to how it will work.

Attendees will be able to access some of the country’s best evidence-based innovations and be reimbursed by NHS England; learn how these innovations have improved efficiencies, benefitted patients and secured cost savings across other NHS organisations; meet the NIA Fellows who represent these innovations and see first-hand how they work; and find out how to replicate these benefits across your organisation.

These innovations include:

  • MyCOPD: Online self-management system for COPD proven to correct 98% of patient inhaler errors without clinical involvement, to reduce acute hospital admissions, improve the quality of patients’ lives and save an average CCG - with a COPD population of around 5,000 patients - £200,000 in the first year alone.
  • The Non-Injectable Arterial Connector (NIC): Patient safety device which stops medication being accidentally given through the arterial lines used to monitor the blood of patients in ICUs and operating theatres. Improves safety and infection control, while offering regional savings of over £156,500 per year.
  • PneuX Prevention System: Patient safety device designed to prevent ventilator-associated pneumonia (VAP), affecting some 20,000 patients each year, around a third of whom will die, with each episode costing the NHS between £10,000 and £20,000.
  • Episcissors-60: Guiding mediolateral episiotomy evidenced to minimise the risk of obstetric anal sphincter injury (OASIS), delivering savings through reduced OASIS repair (£1,625 per patient, litigation costs, and elective caesarean sections.
  • AliveCor’s Kardia: Mobile ECG device for the identification and measurement of atrial fibrillation (AF) - the cause of between 25,000-35,000 strokes in the UK per year.

The events are aimed at procurement leads, medical and clinical directors/leads, nursing directors, transformation leads, STP leads and Directors of Surgical Services across local clinical commissioning groups and provider organisations.

Register via the links below to attend one of four events in Birmingham, Leeds, Oxford and London. Places are limited, so attendees are advised to register as soon as possible.

For more information, email Rebekah Tailor, NIA Communications and Engagement Manager, on